Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer

Obesity Research and Clinical Practice - Tập 7 Số 5 - Trang e330-e341 - 2013
Morihiro Matsuda1, Iichiro Shimomura2
1Institute of Clinical Research, National Hospital Organization, Kure Medical Center, and Chugoku Cancer Center, Hiroshima, Japan
2Department of Metabolic Medicine, Osaka University, Graduate School of Medicine, Osaka, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

Matsuzawa, 1999, Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances, Ann N Y Acad Sci, 892, 146, 10.1111/j.1749-6632.1999.tb07793.x

Matsuzawa, 1995, Visceral fat accumulation and cardiovascular disease, Obes Res, 3, 645S, 10.1002/j.1550-8528.1995.tb00481.x

Hiuge-Shimizu, 2012, Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study), Ann Med, 44, 82, 10.3109/07853890.2010.526138

Kishida, 2012, Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective, Curr Diabetes Rev, 8, 84, 10.2174/157339912799424546

Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183

Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246

Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451

Sies, 1997, Oxidative stress: oxidants and antioxidants, Exp Physiol, 82, 291, 10.1113/expphysiol.1997.sp004024

Furukawa, 2004, Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, 114, 1752, 10.1172/JCI21625

Houstis, 2006, Reactive oxygen species have a causal role in multiple forms of insulin resistance, Nature, 440, 944, 10.1038/nature04634

Matsuoka, 1997, Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells, J Clin Invest, 99, 144, 10.1172/JCI119126

Maddux, 2001, Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid, Diabetes, 50, 404, 10.2337/diabetes.50.2.404

Nakazono, 1991, Does superoxide underlie the pathogenesis of hypertension?, Proc Natl Acad Sci U S A, 88, 10045, 10.1073/pnas.88.22.10045

Ohara, 1993, Hypercholesterolemia increases endothelial superoxide anion production, J Clin Invest, 91, 2546, 10.1172/JCI116491

Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615

Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939

Weindruch, 1997, Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging, N Engl J Med, 337, 986, 10.1056/NEJM199710023371407

Rebrin, 2003, Effects of age and caloric restriction on glutathione redox state in mice, Free Radic Biol Med, 35, 626, 10.1016/S0891-5849(03)00388-5

Grattagliano, 2004, Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats, Exp Gerontol, 39, 1323, 10.1016/j.exger.2004.06.001

Cocco, 2005, Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine, Free Radic Biol Med, 38, 796, 10.1016/j.freeradbiomed.2004.11.034

Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960

Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354

Keaney, 2003, Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study, Arterioscler Thromb Vasc Biol, 23, 434, 10.1161/01.ATV.0000058402.34138.11

Okuno, 2008, Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region, Biochem Biophys Res Commun, 366, 698, 10.1016/j.bbrc.2007.12.001

Okuno, 2010, Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse, Endocr J, 57, 303, 10.1507/endocrj.K09E-113

Kobayashi, 2009, Dysregulated glutathione metabolism links to impaired insulin action in adipocytes, Am J Physiol Endocrinol Metab, 296, E1326, 10.1152/ajpendo.90921.2008

Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, 847, 10.1210/jc.83.3.847

Sartipy, 2003, Monocyte chemoattractant protein 1 in obesity and insulin resistance, Proc Natl Acad Sci U S A, 100, 7265, 10.1073/pnas.1133870100

Friedman, 1998, Leptin and the regulation of body weight in mammals, Nature, 395, 763, 10.1038/27376

Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat Med, 7, 941, 10.1038/90984

Berg, 2001, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nat Med, 7, 947, 10.1038/90992

Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724

Okamoto, 2002, Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice, Circulation, 106, 2767, 10.1161/01.CIR.0000042707.50032.19

Matsuda, 2002, Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis, J Biol Chem, 277, 37487, 10.1074/jbc.M206083200

Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem Biophys Res Commun, 257, 79, 10.1006/bbrc.1999.0255

Spiegelman, 2001, Obesity and the regulation of energy balance, Cell, 104, 531, 10.1016/S0092-8674(01)00240-9

Kahn, 2000, Obesity and insulin resistance, J Clin Invest, 106, 473, 10.1172/JCI10842

Fujita, 2006, Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome, Circ J, 70, 1437, 10.1253/circj.70.1437

Rudich, 1998, Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes, Diabetes, 47, 1562, 10.2337/diabetes.47.10.1562

Tirosh, 1999, Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation, J Biol Chem, 274, 10595, 10.1074/jbc.274.15.10595

Krieger-Brauer, 1992, Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase, J Clin Invest, 89, 1006, 10.1172/JCI115641

Matsuzawa, 2011, The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism, J Atheroscler Thromb, 18, 629, 10.5551/jat.7922

Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, 116, 1494, 10.1172/JCI26498

Tamura, 2008, Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice, Arterioscler Thromb Vasc Biol, 28, 2195, 10.1161/ATVBAHA.108.168633

Ito, 2008, Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue, J Biol Chem, 283, 35715, 10.1074/jbc.M804220200

Suganami, 2005, A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha, Arterioscler Thromb Vasc Biol, 25, 2062, 10.1161/01.ATV.0000183883.72263.13

Suganami, 2007, Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation, Biochem Biophys Res Commun, 354, 45, 10.1016/j.bbrc.2006.12.190

Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J Clin Invest, 116, 3015, 10.1172/JCI28898

Talukdar, 2012, Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase, Nat Med, 18, 1407, 10.1038/nm.2885

Lynch, 2012, Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production, Immunity, 37, 574, 10.1016/j.immuni.2012.06.016

Schipper, 2012, Natural killer T cells in adipose tissue prevent insulin resistance, J Clin Invest, 122, 3343, 10.1172/JCI62739

Curzio, 1987, Possible role of aldehydic lipid peroxidation products as chemoattractants, Int J Tissue React, 9, 295

Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a

Jay, 2006, Oxidative stress and diabetic cardiovascular complications, Free Radic Biol Med, 40, 183, 10.1016/j.freeradbiomed.2005.06.018

Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121

Sasaki, 2012, The role of oxidative stress in the pathogenesis of diabetic vascular complications, Diabet Metab J, 36, 255, 10.4093/dmj.2012.36.4.255

Lee, 1999, Contributions of polyol pathway to oxidative stress in diabetic cataract, FASEB J, 13, 23, 10.1096/fasebj.13.1.23

Obrosova, 2003, Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats, Diabetes, 52, 864, 10.2337/diabetes.52.3.864

Ramana, 2003, Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells, FASEB J, 17, 417, 10.1096/fj.02-0722com

Yabe-Nishimura, 1998, Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications, Pharmacol Rev, 50, 21

Morre, 2000, Surface oxidase and oxidative stress propagation in aging, J Exp Biol, 203, 1513, 10.1242/jeb.203.10.1513

Basta, 2004, Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes, Cardiovasc Res, 63, 582, 10.1016/j.cardiores.2004.05.001

Kaneto, 1999, Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity, Diabetes, 48, 2398, 10.2337/diabetes.48.12.2398

Matsuoka, 2003, Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells, Mol Cell Biol, 23, 6049, 10.1128/MCB.23.17.6049-6062.2003

Kawamori, 2003, Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase, Diabetes, 52, 2896, 10.2337/diabetes.52.12.2896

Zhang, 2005, High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex, Exp Neurol, 191, 318, 10.1016/j.expneurol.2004.10.011

Nagae, 2009, Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension, Circulation, 119, 978, 10.1161/CIRCULATIONAHA.108.824730

Rajagopalan, 1996, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone, J Clin Invest, 97, 1916, 10.1172/JCI118623

Griendling, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494

Frederich, 1992, Tissue-specific nutritional regulation of angiotensinogen in adipose tissue, Hypertension, 19, 339, 10.1161/01.HYP.19.4.339

Prasad, 2004, Renin–angiotensin system and angiotensin receptor blockers in the metabolic syndrome, Circulation, 110, 1507, 10.1161/01.CIR.0000141736.76561.78

Goossens, 2003, Possible involvement of the adipose tissue renin–angiotensin system in the pathophysiology of obesity and obesity-related disorders, Obes Rev, 4, 43, 10.1046/j.1467-789X.2003.00091.x

Kurata, 2006, Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation, Kidney Int, 70, 1717, 10.1038/sj.ki.5001810

Stocker, 2004, Role of oxidative modifications in atherosclerosis, Physiol Rev, 84, 1381, 10.1152/physrev.00047.2003

Guzik, 2004, Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins, Arterioscler Thromb Vasc Biol, 24, 1614, 10.1161/01.ATV.0000139011.94634.9d

Spiekermann, 2003, Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 107, 1383, 10.1161/01.CIR.0000056762.69302.46

Heitzer, 2001, Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease, Circulation, 104, 2673, 10.1161/hc4601.099485

Azumi, 2002, Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase, Arterioscler Thromb Vasc Biol, 22, 1838, 10.1161/01.ATV.0000037101.40667.62

Ginsberg, 2000, Insulin resistance and cardiovascular disease, J Clin Invest, 106, 453, 10.1172/JCI10762

Berneis, 2002, Metabolic origins and clinical significance of LDL heterogeneity, J Lipid Res, 43, 1363, 10.1194/jlr.R200004-JLR200

Nappo, 2002, Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals, J Am Coll Cardiol, 39, 1145, 10.1016/S0735-1097(02)01741-2

Ceriello, 2002, Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment, Circulation, 106, 1211, 10.1161/01.CIR.0000027569.76671.A8

Anderson, 2001, The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes, Atherosclerosis, 154, 475, 10.1016/S0021-9150(00)00499-8

Plotnick, 1997, Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal, JAMA, 278, 1682, 10.1001/jama.1997.03550200058032

Semenkovich, 2006, Insulin resistance and atherosclerosis, J Clin Invest, 116, 1813, 10.1172/JCI29024

Taskinen, 2003, Diabetic dyslipidaemia: from basic research to clinical practice, Diabetologia, 46, 733, 10.1007/s00125-003-1111-y

Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am J Med, 62, 707, 10.1016/0002-9343(77)90874-9

Tall, 1998, An overview of reverse cholesterol transport, Eur Heart J, 19, A31

Navab, 1991, Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J Clin Invest, 88, 2039, 10.1172/JCI115532

Van Lenten, 1995, Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures, J Clin Invest, 96, 2758, 10.1172/JCI118345

Watson, 1995, Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein, J Clin Invest, 96, 2882, 10.1172/JCI118359

Briel, 2009, Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis, BMJ, 338, b92, 10.1136/bmj.b92

Persegol, 2007, Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation, J Lipid Res, 48, 1396, 10.1194/jlr.M600309-JLR200

Nicholls, 2005, Formation of dysfunctional high-density lipoprotein by myeloperoxidase, Trends Cardiovasc Med, 15, 212, 10.1016/j.tcm.2005.06.004

Cowey, 2006, The metabolic syndrome: a high-risk state for cancer?, Am J Pathol, 169, 1505, 10.2353/ajpath.2006.051090

Gallagher, 2011, Minireview: IGF, insulin, and cancer, Endocrinology, 152, 2546, 10.1210/en.2011-0231

Vucenik, 2012, Obesity and cancer risk: evidence, mechanisms, and recommendations, Ann N Y Acad Sci, 1271, 37, 10.1111/j.1749-6632.2012.06750.x

Gao, 2009, Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells, Cancer Sci, 100, 389, 10.1111/j.1349-7006.2008.01053.x

Jaffe, 2008, Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways, Int J Cancer, 123, 2543, 10.1002/ijc.23821

Nishihara, 2008, Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice, World J Gastroenterol, 14, 6473, 10.3748/wjg.14.6473

Kamada, 2007, Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model, J Hepatol, 47, 556, 10.1016/j.jhep.2007.03.020

Harvey, 2011, The growing challenge of obesity and cancer: an inflammatory issue, Ann N Y Acad Sci, 1229, 45, 10.1111/j.1749-6632.2011.06096.x

Hursting, 2010, Energy balance, host-related factors, and cancer progression, J Clin Oncol, 28, 4058, 10.1200/JCO.2010.27.9935

Fiaschi, 2012, Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison, Int J Cell Biol, 2012, 762825, 10.1155/2012/762825

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Marnett, 2000, Oxyradicals and DNA damage, Carcinogenesis, 21, 361, 10.1093/carcin/21.3.361

Storz, 2005, Reactive oxygen species in tumor progression, Front Biosci, 10, 1881, 10.2741/1667

Ferraro, 2006, Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS), Oncogene, 25, 3689, 10.1038/sj.onc.1209409

Shinohara, 2007, Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho, J Biol Chem, 282, 17640, 10.1074/jbc.M609450200

Svineng, 2008, The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function, Connect Tissue Res, 49, 197, 10.1080/03008200802143166

Maulik, 2002, Redox signaling of angiogenesis, Antioxid Redox signal, 4, 805, 10.1089/152308602760598963

Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441

Rosenson, 1999, Inhibition of proinflammatory cytokine production by pravastatin, Lancet, 353, 983, 10.1016/S0140-6736(98)05917-0

Martin-Ventura, 2005, Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month, Stroke, 36, 1796, 10.1161/01.STR.0000174289.34110.b0

Abe, 2008, Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages, Arterioscler Thromb Vasc Biol, 28, 871, 10.1161/ATVBAHA.107.160663

Tsubouchi, 2005, Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement, Free Radic Biol Med, 39, 444, 10.1016/j.freeradbiomed.2005.03.031